Gerhard Hellemann Selected Research

Gerhard Hellemann Research Topics

Disease

13	Schizophrenia (Dementia Praecox) 01/2022 - 10/2012
5	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 08/2007
4	Autistic Disorder (Autism) 01/2023 - 01/2019
3	Inflammation (Inflammations) 01/2023 - 09/2012
3	Autism Spectrum Disorder 01/2023 - 01/2019
3	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2018
3	Anhedonia 01/2021 - 06/2020
3	Bipolar Disorder (Manic Depressive Psychosis) 11/2019 - 06/2007
3	Mania (Manias) 01/2019 - 04/2009
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2016 - 12/2009
2	Substance-Related Disorders (Drug Abuse) 01/2018 - 01/2016
2	Obesity 04/2017 - 06/2007
2	Mental Disorders (Mental Disorder) 04/2017 - 01/2017
2	Weight Gain 04/2017 - 06/2007
2	Overweight 04/2017 - 06/2007
2	Fatigue 01/2016 - 09/2012
2	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 10/2014 - 10/2010
2	Premature Birth (Birth, Premature) 09/2008 - 08/2007
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2022
1	Hemolysis 10/2022
1	Treatment-Resistant Depressive Disorder 01/2021
1	Stroke (Strokes) 01/2021
1	Hypochondriasis 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2020
1	Syndrome (Syndromes) 06/2020
1	Tobacco Use Disorder (Nicotine Dependence) 01/2018
1	Personality Disorders (Personality Disorder) 01/2018
1	Pain (Aches) 01/2016
1	Lethargy 01/2016
1	Sleepiness 01/2016
1	Chronic Hepatitis C 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Cognitive Dysfunction 11/2011
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 10/2010
1	Type 2 Diabetes Mellitus (MODY) 03/2009
1	Weight Loss (Weight Reduction) 06/2007

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2012
6	Antidepressive Agents (Antidepressants)IBA 01/2021 - 08/2007
3	Interleukin-8 (Interleukin 8)IBA 01/2023 - 10/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 09/2012
3	C-Reactive ProteinIBA 01/2023 - 09/2012
3	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2018 - 10/2010
3	Antipsychotic Agents (Antipsychotics)IBA 04/2017 - 12/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 10/2020
2	AntioxidantsIBA 01/2022 - 12/2019
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2022 - 01/2019
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 12/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2018
2	Therapeutic UsesIBA 01/2018 - 07/2015
2	CurcuminIBA 01/2018 - 01/2012
2	Guanfacine (Tenex)FDA LinkGeneric 01/2016 - 01/2016
2	Methylphenidate (Ritalin)FDA LinkGeneric 01/2016 - 12/2009
2	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 10/2014 - 10/2010
1	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Complement System Proteins (Complement)IBA 12/2021
1	Ketamine FDA LinkGeneric 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 10/2020
1	BenzodiazepinesIBA 06/2020
1	SolutionsIBA 06/2020
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2019
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	propylene diquat (PDQ(+))IBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 12/2013
1	Benzoates (Benzoate)IBA 12/2013
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2013
1	Sodium Benzoate FDA Link 12/2013
1	CytokinesIBA 09/2012
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2012
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2009
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 12/2009
1	Proteins (Proteins, Gene)FDA Link 03/2009
1	Estriol (Epiestriol)IBA 09/2008
1	Topiramate (Topamax)FDA LinkGeneric 06/2007
1	sibutramine (Meridia)FDA Link 06/2007

Therapy/Procedure

5	Transcranial Direct Current Stimulation 01/2021 - 07/2015
4	Therapeutics 10/2022 - 12/2013
1	Episode of Care 11/2019
1	Cognitive Training 01/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Ambulatory Care (Outpatient Care) 01/2016
1	Transcranial Magnetic Stimulation 11/2014
1	Electrodes (Electrode) 10/2012
1	Activities of Daily Living (ADL) 01/2012